Sharp Therapeutics postpones annual meeting to July 21, requires shareholders to recast votes

Management
โดย Newsfile Corp.·Read original
Summary · why it matters

Sharp Therapeutics Corp. has postponed its annual shareholder meeting to July 21, 2026, from the original June 30 date, and filed an amended and restated management information circular to include a resolution re-approving the company's stock option plan. The plan resolution was omitted from the original May 27 circular and proxy materials, so shareholders must disregard any previously submitted voting instructions and cast new votes using the updated proxy or voting instruction form. Proxies must be received by 10:00 a.m. Toronto time on July 17, 2026. The amended documents will be available on SEDAR+.

Impact on stocks 2

Energy Transition & Power Demand▲ · 1 stocks
Others▲ · 1 stocks
SHRXF
SHRXF
± MixedRegulationrelevance

Company postponed meeting and requires re-vote due to omitted stock option plan resolution; procedural issue with unclear market impact.

Off-coverage companies 1

Sharp Therapeutics Corp.Private± Mixed
Regulationrelevance

Company is the subject; postponed annual meeting and amended circular due to omitted stock option plan resolution, requiring shareholders to recast votes.

© 2026 MarketDXNews